Home » Topics » BioWorld Science

BioWorld Science
RSS

Addicted to bile acids

Aug. 2, 2018

Zinc transporter affects insulin secretion

Aug. 2, 2018

New phase I trial explores use of CERC-301 for neurogenic orthostatic hypotension in Parkinson's

Aug. 1, 2018

Renji Hospital synthesizes aaptamine alkaloid derivatives

Aug. 1, 2018

TGF-beta receptor type-1/2 inhibitors discovered at Bristol-Myers Squibb

Aug. 1, 2018

ViiV Healthcare UK patents HIV integrase inhibitors

Aug. 1, 2018

Enanta Pharmaceuticals identifies respiratory syncytial virus inhibitors

Aug. 1, 2018

New kinase inhibitors developed at IMPACT Therapeutics

Aug. 1, 2018

NeuroActiva presents phase I data for NA-831 for Alzheimer's disease

Aug. 1, 2018

Neuralstem begins phase II study of NSI-566 for ischemic stroke

Aug. 1, 2018

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...